The research team adapted an existing platform to facilitate the analysis of a large amount and variety of data while ensuring they remain protected
Read moreSOM Biotech will attend the “Chiba Global Healthcare Business Forum 2021” on February 3rd – 4th, which will take place digitally due to the pandemic situation.
Read moreAptadel Therapeutics is a preclinical company co-founded by IDIBELL focused on developing a new platform for targeted therapy against cancer. This platform consists of nanoparticles loaded with therap...
Read moreLAVA Therapeutics, a biotech company pioneering the development of bispecific antibodies to engage gamma-delta T cells for cancer therapies, today announced the closing of an oversubscribed $83 millio...
Read moreSplice Bio, a biotech company based on technology developed in the Muir Lab at Princeton University, announced today a new investment into the Company led by Ysios Capital and joined by Asabys Partner...
Read moreScience is collaborative by nature, since scientific knowledge only advances, step by step, through combined efforts and findings. Nevertheless, there is often a lack of communication regarding the mo...
Read moreDroplite,a spinoff of the Institute of Photonics Ciences (ICFO), located in the vibrant Parc Cientific de Barcelona (PCB), has recently started the industrial design and manufacturing development o...
Read moreFlomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for COVID19 detection and research.
Read moreDr. Antonella Consiglio's group will receive 150,000 euros for an 18-month project. The project aims to develop a stem cell-based diagnostic method for autoimmune encephalitis detection.
Read moreThe COVID-19 situation has a major impact on oncological clinical routine practice with collateral effects on patient’s life, OncoDNA offers to labs and oncologists a free access to its Clinical Dec...
Read morePeople registered on this platform will help to include the vision of patients in the process of developing clinical trials in pediatrics.
Read moreRounds at Ability, Elma and Vytrus and “la Caixa” grants, among the top headlines in September
Read more